JULIA BORKOWICZ: Open Payments
NPI 1720216823 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,384 in 150 payments from 15 companies in 2025. Trend: 2023 $2,350 · 2024 $2,332 · 2025 $2,384
Food & beverage: $2,384
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $481 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $298 |
| Janssen Biotech, Inc. | 21 | $292 |
| Aimmune Therapeutics, Inc. | 26 | $247 |
| PFIZER INC. | 16 | $193 |
| GENZYME CORPORATION | 6 | $183 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Lilly USA, LLC | 5 | $116 |
| Celltrion USA Inc. | 5 | $106 |
| Ipsen Biopharmaceuticals, Inc | 5 | $94 |
Products named: TREMFYA, XIFAXAN, ZENPEP, MAVYRET, DUPIXENT, VELSIPITY, CREON, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
